Stories & News

3 Questions with Dr. Erika Moore

Feb. 22, 2023 The Lupus Research Alliance has funded some of the biggest breakthroughs in lupus research, and we’re pleased...

LRA Joins NIAMS Coalition in Supporting Congressional Act Promoting Clinical Trial Diversity

The Lupus Research Alliance and Lupus Therapeutics support diversity in clinical trials to ensure that populations that test potential...

Recognizing a Lupus Research Hero: Kaamilah Gilyard

February 3, 2023 This month, we celebrate lupus warrior Kaamilah Gilyard who is determined to change the lives of future...

Join Kerry Harrington – Run Upcoming NYC Half-Marathon to Support Lupus Research

January 27, 2023 At 23, Kerry Harrington is running the NYC Half Marathon with LRA’s Team Life Without Lupus for...

2022 LRA Advocacy a Success for Lupus Research

January 6, 2023 With the help of our advocates throughout the year, 2022 was a year of great action and...

New Year’s Message from LRA President & CEO Albert Roy

NEW YEAR'S MESSAGE FROM LRA PRESIDENT & CEOAs we welcome in the new year, hear from Lupus Research Alliance President...

LRA-Funded Researchers Presented Cutting Edge Methods and Discoveries at the Annual Rheumatology Meeting

November, 2022 The Lupus Research Alliance (LRA) aims to support the best science to prevent, treat and cure lupus. This year...

Make a Difference for Lupus Research in 60 Seconds!

November 10, 2022 As you probably know, the LRA and our advocates were highly instrumental in creating the Department of...

Lupus Wins Big at Dedicated NY Jets Game

November 2, 2022 Last Sunday brought major fundraising support to the Lupus Research Alliance (LRA) during Lupus Awareness Day at the...

Jets and Lupus Research Alliance to Host Lupus Awareness Day on Sunday

October 26, 2022 The New York Jets and Lupus Research Alliance will host Lupus Awareness Day on October 30, 2022,...

From Struggling to Walk to Running NYC TCS Marathon!

October 18, 2022 Ten years ago, Megan Rosa struggled to walk because of her lupus – now she’s training for...

Lupkynis® (voclosporin) Granted Marketing Authorization in the European Union for Lupus Nephritis

September 21, 2022 Lupkynis® (voclosporin) was just granted marketing authorization in the European Union as a new treatment for adults...